Please login to the form below

Not currently logged in
Email:
Password:

Martin Reeves joins Oxford BioDynamics

He takes up a senior vice president role

Martin ReevesOxford BioDynamics – a spin out company from the University of Oxford – has appointed Martin Reeves as its new senior vice president, commercial development.

His career to date has seen him hold positions such as head of business development, global branded products at Teva Pharmaceuticals, VP of business development and strategic planning at Cephalon and various project management roles at Wyeth-Ayerst and SmithKline Beecham.

Christian Hoyer Millar, CEO at Oxford BioDynamics, said: “His considerable experience in business development within the sector will be a great asset to Oxford BioDynamics as we look to leverage IP licensing opportunities with our award-winning, proprietary technology platform EpiSwitch.”

23rd March 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics